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Introduction
Systemic lupus erythematosus (SLE) is a multisystem auto-
immune disease characterized by a variable clinical picture
and serological abnormalities. Children and adolescents
generally have a more severe disease presentation; develop
disease damage more quickly than adults with SLE. Diffuse
alveolar hemorrhage (DAH) is a rare life-threatening com-
plication in SLE. In this report a case of infantile onset
SLE with DAH and negative ANA is presented.
Objectives
In this report a case of infantile onset SLE with DAH
and negative ANA is presented.
Methods
Case report
A 1-year-old boy presented with petechia on his legs.
Physical examination was notable for ecchymoses and
petechiae in the lower extremities. He had a 2/6 systolic
murmur and hepatomegaly. Arterial blood pressure was
121/81 mm/Hg (> 95 th percantile). On admission, the
patient’s hemoglobin was 7.2 g/dL, white blood cells
(WBC) 15900/mm3, platelets 50200/mm3, BUN 25 mg/dL,
creatinine 0.53 mg/dL, alanine aminotransferase 120 U/l,
aspartate aminotransferase 99 U/l. Urinalysis revealed Ph
5.0, density 1020, blood 3+ and protein 2+. Spot urine pro-
tein creatinin ratio was 5.7 mg/mg. Complements C3 was
23 mg/dL (90-180 mg/dL) and C4 was 2.9 mg/dL (10-40
mg/dL). Direct Coombs was +4 positive. Bone marrow
aspiration revealed hypercellular bone marrow with an
increased myeloid series. Echocardiography revealed peri-
cardial effusion.With the preliminary diagnosis of SLE, a
renal biopsy was performed. Diffuse global proliferative
nephritis (Class IV-G(A)) was observed. Glomerular
deposits of IgG, IgM and complement C3 was seen with
immunofluorescence microscopy. However, antinuclear
antibody (ANA) and anti-double-stranded DNA were
negative.
Results
The patient was diagnosed as SLE with Systemic Lupus
International Collaborating Clinics (SLICC) criteria which
were reported to be more sensitive than ACR (American
College of Rheumatology) criteria. The initial SLE Disease
Activity Index (SLEDAI) was 15. Intravenous methylpred-
nisolone was administered at a dose of 30 mg/kg/day. In
the second day of treatment he suddenly developed dys-
pnea. Chest radiograph demonstrated diffuse alveolar sha-
dows in both lungs without cardiyomegaly. He was
transferred to the intensive care unit with the diagnosis of
acute respiratory distress syndrome (ARDS) and supported
with mechanical ventilation. During this support severe
lung bleeding was inspected from the endotracheal tube.
Intravenous cyclophosphamide 500 mg/m2 was added to
therapy and response to treatment was observed in a few
days. He was successfully weaned off ventilator support
after 7 days. In his 4th follow-up month, he is in remission
with monthly cyclophosphamide and prednisolone.
Conclusion
Children and adolescents generally have a more severe
disease presentation; develop disease damage more
quickly than adults with SLE. Diffuse alveolar hemor-
rhage (DAH) is a rare life-threatening complication of
SLE. It is an uncommon complication with estimates ran-
ging from < 2 to 5.4 % in cohorts of lupus patients. DAH
usually occurs in patients with established diagnosis of
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SLE; however, cases have been reported where DAH was
initial presentation of SLE. DAH can often mimic severe
pneumonia or ARDS. Optimal management of DAH has
not been established. Use of cyclophosphamide has been
linked to better survival as in our case.This case is having
a combination of the rarely known presenting features of
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